Last updated: 11/15/2018 21:20:10
Prospective Household Contact Study to compare the frequency of clinical pertussis disease following household exposure in children previously vaccinated with a primary course of 3 doses of SB Biologicals combined acellular tricomponent DTPa vaccine and in children not immunized against pertussis
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Trial overview
Official title: Prospective Household Contact Study to compare the frequency of clinical pertussis disease following household exposure in children previously vaccinated with a primary course of 3 doses of SB Biologicals combined acellular tricomponent DTPa vaccine and in children not immunized against pertussis
Trial description: Prospective Household Contact Study to compare the frequency of clinical pertussis disease following household exposure in children previously vaccinated with a primary course of 3 doses of SB Biologicals combined acellular tricomponent DTPa vaccine and in children not immunized against pertussis
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
Schmitt HJ et al. (1996) Efficacy of acellular pertussis vaccine in early childhood after household exposure. JAMA. 275 (1): 37-41.
Medical condition
acellular pertussis, Diphtheria, Tetanus
Product
Diphtheria, Tetanus, Acellular Pertussis Vaccine Adsorbed
Collaborators
Not applicable
Study date(s)
N/A to Invalid Date
Type
Not applicable
Phase
3
Participation criteria
Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable
Inclusion and exclusion criteria
Trial location(s)
This study does not involve prospective enrollment of participants.
Study documents
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Not applicable
Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
Not applicable
Plain language summaries
Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website